...
首页> 外文期刊>World Journal of Gastroenterology >Preoperative biliary drainage in patients with hilar cholangiocarcinoma undergoing major hepatectomy
【24h】

Preoperative biliary drainage in patients with hilar cholangiocarcinoma undergoing major hepatectomy

机译:大肝切除术的肝门胆管癌患者术前胆道引流

获取原文
   

获取外文期刊封面封底 >>

       

摘要

AIM: To investigate the effect of preoperative biliary drainage (PBD) in jaundiced patients with hilar cholangiocarcinoma (HCCA) undergoing major liver resections. METHODS: An observational study was carried out by reviewing a prospectively maintained database of HCCA patients who underwent major liver resection for curative therapy from January 2002 to December 2012. Patients were divided into two groups based on whether PBD was performed: a drained group and an undrained group. Patient baseline characteristics, preoperative factors, perioperative and short-term postoperative outcomes were compared between the two groups. Risk factors for postoperative complications were also analyzed by logistic regression test with calculating OR and 95%CI. RESULTS: In total, 78 jaundiced patients with HCCA underwent major liver resection: 32 had PBD prior to operation while 46 did not have PBD. The two groups were comparable with respect to age, sex, body mass index and co-morbidities. Furthermore, there was no significant difference in the total bilirubin (TBIL) levels between the drained group and the undrained group at admission (294.2 ± 135.7 vs 254.0 ± 63.5, P = 0.126). PBD significantly improved liver function, reducing not only the bilirubin levels but also other liver enzymes. The preoperative TBIL level was significantly lower in the drained group as compared to the undrained group (108.1 ± 60.6 vs 265.7 ± 69.1, P = 0.000). The rate of overall postoperative complications (53.1% vs 58.7%, P = 0.626), reoperation rate (6.3% vs 6.5%, P = 1.000), postoperative hospital stay (16.5 vs 15.0, P = 0.221) and mortality (9.4% vs 4.3%, P = 0.673) were similar between the two groups. In addition, there was no significant difference in infectious complications (40.6% vs 23.9%, P = 0.116) and noninfectious complications (31.3% vs 47.8%, P = 0.143) between the two groups. Univariate and multivariate analyses revealed that preoperative TBIL > 170 μmol/L (OR = 13.690, 95%CI: 1.275-147.028, P = 0.031), Bismuth-Corlette classification (OR = 0.013, 95%CI: 0.001-0.166, P = 0.001) and extended liver resection (OR = 14.010, 95%CI: 1.130-173.646, P = 0.040) were independent risk factors for postoperative complications. CONCLUSION: Overall postoperative morbidity and mortality rates after major liver resection are not improved by PBD in HCCA patients with jaundice. Preoperative TBIL > 170 μmol/L, Bismuth-Corlette classification and extended liver resection are independent risk factors linked to postoperative complications.
机译:目的:探讨术前胆道引流(PBD)对接受大手术肝切除的黄疸型肝门胆管癌(HCCA)患者的影响。方法:通过观察前瞻性维护的2002年1月至2012年12月接受大肝切除术治疗的HCCA患者数据库,进行了一项观察性研究。根据是否进行PBD的不同,将患者分为两组:引流组和对照组。不排水的群体。比较两组患者的基线特征,术前因素,围手术期和短期术后结局。术后并发症的危险因素也通过计算OR和95%CI的逻辑回归测试进行了分析。结果:总共78例HCCA的黄疸患者接受了大肝切除术:术前32例进行了PBD,而46例未进行PBD。两组在年龄,性别,体重指数和合并症方面具有可比性。此外,入院时引流组和不引流组之间总胆红素(TBIL)水平无显着差异(294.2±135.7 vs 254.0±63.5,P = 0.126)。 PBD显着改善了肝功能,不仅降低了胆红素水平,还降低了其他肝酶。与不引流组相比,引流组术前TBIL水平显着降低(108.1±60.6 vs 265.7±69.1,P = 0.000)。术后总体并发症发生率(53.1%vs 58.7%,P = 0.626),再次手术率(6.3%vs 6.5%,P = 1.000),术后住院时间(16.5 vs 15.0,P = 0.221)和死亡率(9.4%vs.两组之间的差异为4.3%,P = 0.673)。此外,两组的感染并发症(40.6%vs 23.9%,P = 0.116)和非感染并发症(31.3%vs 47.8%,P = 0.143)没有显着差异。单因素和多因素分析显示术前TBIL> 170μmol/ L(OR = 13.690,95%CI:1.275-147.028,P = 0.031),Bistruth-Corlette分类(OR = 0.013,95%CI:0.001-0.166,P = 0.001)和扩大的肝切除术(OR = 14.010,95%CI:1.130-173.646,P = 0.040)是术后并发症的独立危险因素。结论:PBD不能改善HCCA黄疸患者的大肝切除术后总体发病率和死亡率。术前TBIL> 170μmol/ L,Bistuth-Corlette分型和扩大肝切除术是与术后并发症相关的独立危险因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号